|
1
|
Parkin DM, Bray MF, Ferlay MJ and Pisani
P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schütte K, Bornschein J and Malfertheiner
P: Liver cancer-epidemiological trends and risk factors. Dig Dis.
27:80–92. 2009. View Article : Google Scholar
|
|
3
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cai MY, Tong ZT, Zheng F, Liao YJ, Wang Y,
Rao HL, Chen YC, Wu QL, Liu YH, Guan XY, et al: EZH2 protein: A
promising immunomarker for the detection of liver cancers in liver
needle biopsies. Gut. 60:967–976. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Center MM and Jemal A: International
trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers
Prev. 20:2362–2368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi
CG and Lai CL: Early detection of liver cancer increases the chance
of treatment: Hong Kong experience. Hepatology. 31:330–335. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bruix J and Sherman M: Practice Guidelines
Committee, American Association for the Study of Liver Diseases.
Hepatology. 42:1208–1236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chong CC, Wong GL and Lai PB: Impact of
antiviral therapy on post-hepatectomy outcome for hepatitis
B-related liver cancer. World J Gastroenterol. 20:6006–6012. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Olsen SK, Brown RS and Siegel AB: Liver
cancer: Review of current treatment with a focus on targeted
molecular therapies. Therap Adv Gastroenterol. 3:55–66. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stevenson BR, Siliciano JD, Mooseker MS
and Goodenough DA: Identification of ZO-1: A high molecular weight
polypeptide associated with the tight junction (zonula occludens)
in a variety of epithelia. J Cell Biol. 103:755–766. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gumbiner B, Lowenkopf T and Apatira D:
Identification of a 160-kDa polypeptide that binds to the tight
junction protein ZO-1. Proc Natl Acad Sci USA. 88:3460–3464. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haskins J, Gu L, Wittchen ES, Hibbard J
and Stevenson BR: ZO-3, a novel member of the MAGUK protein family
found at the tight junction, interacts with ZO-1 and occludin. J
Cell Biol. 141:199–208. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Willott E, Balda MS, Fanning AS, Jameson
B, Van Itallie C and Anderson JM: The tight junction protein ZO-1
is homologous to the Drosophila discs-large tumor suppressor
protein of septate junctions. Proc Natl Acad Sci USA. 90:7834–7838.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsukita S, Furuse M and Itoh M: Molecular
architecture of tight junctions: Occludin and ZO-1. Soc Gen Physiol
Ser. 52:69–76. 1997.PubMed/NCBI
|
|
15
|
Fanning AS, Jameson BJ, Jesaitis LA and
Anderson JM: The tight junction protein ZO-1 establishes a link
between the transmembrane protein occludin and the actin
cytoskeleton. J Biol Chem. 273:29745–29753. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wittchen ES, Haskins J and Stevenson BR:
Protein interactions at the tight junction. Actin has multiple
binding partners, and ZO-1 forms independent complexes with ZO-2
and ZO-3. J Biol Chem. 274:35179–35185. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Itoh M, Nagafuchi A, Moroi S and Tsukita
S: Involvement of ZO-1 in Cadherin-based cell adhesion through its
direct binding to α catenin and actin filaments. J Cell Biol.
138:181–192. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rajasekaran AK, Hojo M, Huima T and
Rodriguez-Boulan E: Catenins and zonula occludens-1 form a complex
during early stages in the assembly of tight junctions. J Cell
Biol. 132:451–463. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Provost E and Rimm DL: Controversies at
the cytoplasmic face of the cadherin-based adhesion complex. Curr
Opin Cell Biol. 11:567–572. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fanning AS and Anderson JM: PDZ domains:
Fundamental building blocks in the organization of protein
complexes at the plasma membrane. J Clin Invest. 103:767–772. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mauro L, Bartucci M, Morelli C, Andò S and
Surmacz E: IGF-I receptor-induced cell-cell adhesion of MCF-7
breast cancer cells requires the expression of junction protein
ZO-1. J Biol Chem. 276:39892–39897. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hoover KB, Liao SY and Bryant PJ: Loss of
the Tight Junction MAGUK ZO-1 in breast cancer: Relationship to
glandular differentiation and Loss of heterozygosity. Am J Pathol.
153:1767–1773. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kaihara T, Kusaka T, Nishi M, Kawamata H,
Imura J, Kitajima K, Itoh-Minami R, Aoyama N, Kasuga M, Oda Y, et
al: Dedifferentiation and decreased expression of adhesion
molecules, E-cadherin and ZO-1, in colorectal cancer are closely
related to liver metastasis. J Exp Clin Cancer Res. 22:117–123.
2003.PubMed/NCBI
|
|
24
|
Kimura Y, Shiozaki H, Hirao M, Maeno Y,
Doki Y, Inoue M, Monden T, Ando-Akatsuka Y, Furuse M, Tsukita S, et
al: Expression of occludin, tight-junction-associated protein, in
human digestive tract. Am J Pathol. 151:45–54. 1997.PubMed/NCBI
|
|
25
|
Polette M, Mestdagt M, Bindels S,
Nawrocki-Raby B, Hunziker W, Foidart JM, Birembaut P and Gilles C:
Beta-catenin and ZO-1: Shuttle molecules Involved in tumor
Invasion-associated epithelial-mesenchymal transition processes.
Cells Tissues Organs. 185:61–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Akiba J, Nakashima O, Hattori S, Tanikawa
K, Takenaka M, Nakayama M, Kondo R, Nomura Y, Koura K, Ueda K, et
al: Clinicopathologic analysis of combined
hepatocellular-cholangiocarcinoma according to the latest WHO
classification. Am J Surg Pathol. 37:496–505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pirisi M, Leutner M, Pinato DJ, Avellini
C, Carsana L, Toniutto P, Fabris C and Boldorini R: Reliability and
reproducibility of the edmondson grading of hepatocellular
carcinoma using paired core biopsy and surgical resection
specimens. Arch Pathol Lab Med. 134:1818–1822. 2010.PubMed/NCBI
|
|
28
|
Yu S, Liu H and Luo L: Analysis of
relative gene expression using different real-time quantitative
PCR. Acta Agronomica Sinica. 33:1214–1218. 2007.(In Chinese).
|
|
29
|
Yang Y, Liu YM, Wei MY, Wu YF, Gao JH, Liu
L, Zhou WP, Wang HY and Wu MC: The liver tissue bank and clinical
database in China. Front Med China. 4:443–447. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fares N and Péron JM: Epidemiology,
natural history, and risk factors of liver cancer. Rev Prat.
63(216-217): 220–222. 2013.(In French).
|
|
31
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT
and Fan ST: Liver transplantation for liver cancer: The Hong Kong
experience. J Hepatobiliary Pancreat Sci. 17:548–554. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Amram ML, Benamran DA and Roth AD:
Targeted therapies in digestive oncology. Rev Med Suisse.
7:1131-1132–1134-1136. 2011.(In French).
|
|
34
|
Jain S, Singhal S, Lee P and Xu R:
Molecular genetics of hepatocellular neoplasia. Am J Transl Res.
2:105–118. 2010.PubMed/NCBI
|
|
35
|
Furuse M, Itoh M, Hirase T, Nagafuchi A,
Yonemura S and Tsukita S and Tsukita S: Direct association of
occludin with ZO-1 and its possible involvement in the localization
of occludin at tight junctions. J Cell Biol. 127:1617–1626. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yamamoto T, Harada N, Kano K, Taya S,
Canaani E, Matsuura Y, Mizoguchi A, Ide C and Kaibuchi K: The Ras
target AF-6 interacts with ZO-1 and serves as a peripheral
component of tight junctions in epithelial cells. J Cell Biol.
139:785–795. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Van Itallie CM, Balda MS and Anderson JM:
Epidermal growth factor induces tyrosine phosphorylation and
reorganization of the tight junction protein ZO-1 in A431 cells. J
Cell Sci. 108:1735–1742. 1995.PubMed/NCBI
|
|
38
|
Antonetti DA, Barber AJ, Hollinger LA,
Wolpert EB and Gardner TW: Vascular endothelial growth factor
induces rapid phosphorylation of tight junction proteins occludin
and zonula occluden 1. A potential mechanism for vascular
permeability in diabetic retinopathy and tumors. J Biol Chem.
274:23463–23467. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Merwin JR, Anderson JM, Kocher O, Van
Itallie CM and Madri JA: Transforming growth factor beta 1
modulates extracellular matrix organization and cell-cell
junctional complex formation during in vitro angiogenesis. J Cell
Physiol. 142:117–128. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Giri S, Poindexter KM, Sundar SN and
Firestone GL: Arecoline induced disruption of expression and
localization of the tight junctional protein ZO-1 is dependent on
the HER 2 expression in human endometrial Ishikawa cells. BMC Cell
Biol. 11:532010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Németh Z, Szász AM, Somorácz Á, Tátrai P,
Németh J, Gyorffy H, Szíjártó A, Kupcsulik P, Kiss A and Schaff Z:
Zonula occludens-1, occludin, and E-cadherin protein expression in
biliary tract cancers. Pathol Oncol Res. 15:533–539. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Martin TA, Watkins G, Mansel RE and Jiang
WG: Loss of tight junction plaque molecules in breast cancer
tissues is associated with a poor prognosis in patients with breast
cancer. Eur J Cancer. 40:2717–2725. 2004. View Article : Google Scholar : PubMed/NCBI
|
